EP1772450A1 — Method for producing 1,2-dihydropyridine-2-one compound
Assigned to Eisai R&D Management Co Ltd · Expires 2007-04-11 · 19y expired
What this patent protects
Disclosed is a method for commercially producing a 1,2-dihydropyrldine-2-one compound represented by the following formula (III) (wherein the ring A and ring B are as defined below and the ring C represents an optionally substituted phenyl group) with high yield and high purity b…
USPTO Abstract
Disclosed is a method for commercially producing a 1,2-dihydropyrldine-2-one compound represented by the following formula (III) (wherein the ring A and ring B are as defined below and the ring C represents an optionally substituted phenyl group) with high yield and high purity by reacting a compound represented by the following formula (I) (wherein the ring A represents an optionally substituted 2-pyridyl group, the ring B represents an optionally substituted phenyl group, and X represents a leaving group) with a boronic acid derivative in the presence of a palladium compound, a copper compound, a phosphorus compound and a base.
Drugs covered by this patent
- Fycompa (PERAMPANEL) · Catalyst Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.